CClinicalTrials.gg
Status unknownNCT00591487Updated Jan 11, 2008

Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy

A Phase 3 interventional study of Lidocaine in Healthy, sponsored by Hospital Militar de Santiago. Status unknown at 1 site in Chile. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-01-11.

Sponsored by Hospital Militar de Santiago · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2007), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Phase 3
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

RCT of S/E of lidocaine infiltration in tumescent technique.

02

Conditions studied

  • Healthy

Keywords

  • suction
  • assisted
  • lipectomy
  • liposuction
  • contour
  • cosmetic
  • plastic
  • surgery
  • Klein
  • tumescent
  • technique
  • Healthy women wanting Suction Assisted Lipectomy
03

In context

Lead sponsor

This is the only study on the registry with Hospital Militar de Santiago as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Woman
  • I or II of the Classification of the American Society of Anesthesiologists.
  • Completed high school.
  • Between 18 and 40 years old
  • At least suction of entire abdomen and back
  • Body mass index between 20 and 27
  • Accept written informed consent

Exclusion criteria

Exclusion Criteria:

  • Associated surgery
  • Hypersensibility to (Cefazolin or Clindamycin, Lidocaine, Ketorolac, Morphine, Remifentanyl, Propofol, Tramadol).
  • Pregnancy
  • Previous surgery to abdominal wall or back, including cesarean.
  • Abdominal wall hernia
  • Previous liposuction
  • Active psychosis
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Care provider)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    I

    Infiltration with 0.9% saline+1:1,000,000 epinephrine+0.06% Lidocaine

    Drug: Lidocaine

  • Placebo comparator
    II

    Infiltration with 0.9% saline+1:1,000,000 epinephrine

    Drug: Lidocaine

Interventions

  • DrugLidocaine

    Subcutaneous infiltration with Active/Placebo solutions with tumescent technique previous to suction assisted lipectomy. Patient abdomen and back will be divided in 4 zones anterior and posterior, one side (left or right) will be infiltrated with active solution and the other with placebo. The allocation of the side will be made with random numbers.

06

What researchers measure

Primary outcomes

  1. Pain (VSA)

    Time frame: 1, 6, 12, 18 and 24 post operative hours

Secondary outcomes

  1. Rescue medication

    Time frame: 1, 6, 12, 15 and 24 hours postoperative

  2. Nausea, emesis, arrythmia, seizures, arrest, shock, death.

    Time frame: 24 hours postoperative

07

Study locations

1 site
  • Hospital Militar de Santiago
    Santiago, RM, Chile
08

References and documents

Publications

  • Kaplan B, Moy RL. Comparison of room temperature and warmed local anesthetic solution for tumescent liposuction. A randomized double-blind study. Dermatol Surg. 1996 Aug;22(8):707-9. doi: 10.1111/j.1524-4725.1996.tb00621.x. PubMed 8780763 ↗
  • Yang CH, Hsu HC, Shen SC, Juan WH, Hong HS, Chen CH. Warm and neutral tumescent anesthetic solutions are essential factors for a less painful injection. Dermatol Surg. 2006 Sep;32(9):1119-22; discussion 1123. doi: 10.1111/j.1524-4725.2006.32254.x. PubMed 16970691 ↗
  • Rubin JP, Bierman C, Rosow CE, Arthur GR, Chang Y, Courtiss EH, May JW Jr. The tumescent technique: the effect of high tissue pressure and dilute epinephrine on absorption of lidocaine. Plast Reconstr Surg. 1999 Mar;103(3):990-6; discussion 997-1002. PubMed 10077095 ↗
  • Rubin JP, Xie Z, Davidson C, Rosow CE, Chang Y, May JW Jr. Rapid absorption of tumescent lidocaine above the clavicles: a prospective clinical study. Plast Reconstr Surg. 2005 May;115(6):1744-51. doi: 10.1097/01.prs.0000161678.10555.53. PubMed 15861085 ↗
  • Danilla S, Fontbona M, de Valdes VD, Dagnino B, Sorolla JP, Israel G, Searle S, Norambuena H, Cabello R. Analgesic efficacy of lidocaine for suction-assisted lipectomy with tumescent technique under general anesthesia: a randomized, double-masked, controlled trial. Plast Reconstr Surg. 2013 Aug;132(2):327-332. doi: 10.1097/PRS.0b013e3182958b20. PubMed 23897332 ↗

Related links

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 11, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00591487
Lead sponsor
Hospital Militar de Santiago
First posted
Jan 11, 2008
Start date
Dec 2007
Primary completion
Dec 2008 (estimated)
Last update
Jan 11, 2008

Study contacts

Stefan Danilla, MD, MSc
principal investigator · Hospital Militar de Santiago
Guillermo Israel, MD
study chair · Hospital Militar de Santiago
Montserrat Fontbona, MD
study chair · Hospital Militar de Santiago
Rodrigo Cabello, MD
study director · Hospital Militar de Santiago

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion